Guest guest Posted January 19, 2006 Report Share Posted January 19, 2006 An article on the first American patient with nephropathy due to ingestion of Chinese herbs: http://tinyurl.com/c4hes The article cites the Belgian 1990 case a few times. Belgian and foreign media have indeed widely reported on this regretful event. However, media reporters have not been so savvy to report on the latest outcome of the case in Belgium: after 12 years in court, the judge finally ruled that the link between the slimming herbs and the nephropathy had not been proven. The Belgian company Medichin organized a press conference upon hearing this. One reporter came to the press conference, and his article was refused by his editor, and was never published. The judge based his ruling upon the fact that the evidence had been manipulated (pure aristolochic acid had been injected into the samples). Incurance companies still have time left to appeal to the highest court in Belgium. Another case has started, in which Chris Dhaenens, an expert, acts as a prosecutor to find out who manipulated the evidence. Regards, Tom. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 19, 2006 Report Share Posted January 19, 2006 > An article on the first American patient with nephropathy due to ingestion > of Chinese herbs: http://tinyurl.com/c4hes I was deposed regarding the case discussed in this article (the patient had taken a Blue Poppy Rx which DID NOT CONTAIN AA) and I had to explain our company's manufacturing and QA procedures under oath which insure/insured that there was no AA in our RX the patient had taken. As part of this process, I got to learn about the QA procedures of the company/companies whose products did contain AA. It would not be fair of me to disclose the name(s) of those company(ies), but I was horrified by this/these company(ies)'s lack of professionalism and QA. This underscores the improtance of the principle of Caveat Emptor, Let the Buyer Beware. Practitioners need to exercise due diligence when buying and prescribing herbal products. This means requesting Certificates of Analysis (COAs) as well as lab analysis reports for contaminants (microbes, heavy metals, pesticides) and adulterants. Practitioners should not assume that all companies selling Chinese herbal medicines are equal. What I can say is that the company(ies) involved in this case is/are one/some of the biggest and best know in this industry. Hopefully it/they learned their lesson and have improved their QA procedures, but its up to the prescribing practitioner to make sure of this. Bob Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.